US Stock MarketDetailed Quotes

TOVX Theriva Biologics

Watchlist
  • 0.4845
  • +0.0262+5.72%
Close Mar 27 16:00 ET
8.31MMarket Cap-425P/E (TTM)

Theriva Biologics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-15.40%4.22M
15.80%5.82M
21.78%5.18M
51.19%21.58M
38.97%7.32M
52.24%4.99M
57.21%5.03M
67.60%4.25M
40.49%14.27M
146.95%5.27M
Selling and administrative expenses
-91.23%212K
74.37%2.69M
32.99%2.2M
52.27%9.86M
70.80%4.25M
85.42%2.42M
21.82%1.54M
16.63%1.66M
28.73%6.47M
115.61%2.49M
-General and administrative expense
-91.23%212K
74.37%2.69M
32.99%2.2M
52.27%9.86M
70.80%4.25M
85.42%2.42M
21.82%1.54M
16.63%1.66M
28.73%6.47M
115.61%2.49M
Research and development costs
55.88%4.01M
-10.10%3.13M
14.63%2.98M
50.29%11.72M
10.51%3.07M
30.32%2.57M
80.38%3.49M
132.29%2.6M
52.02%7.8M
183.86%2.78M
Operating profit
15.40%-4.22M
-15.80%-5.82M
-21.78%-5.18M
-51.19%-21.58M
-38.97%-7.32M
-52.24%-4.99M
-57.21%-5.03M
-67.60%-4.25M
-40.49%-14.27M
-146.95%-5.27M
Net non-operating interest income expense
124.71%382K
1,365.38%381K
18,100.00%364K
8,433.33%512K
15,650.00%315K
8,400.00%170K
1,200.00%26K
2K
-86.36%6K
2K
Non-operating interest income
124.71%382K
1,365.38%381K
18,100.00%364K
8,433.33%512K
15,650.00%315K
8,400.00%170K
1,200.00%26K
--2K
-86.36%6K
--2K
Other net income (expense)
166.67%6K
55.56%-4K
126.09%6K
-41K
-1K
-9K
-9K
-23K
Gain on sale of security
166.67%6K
55.56%-4K
126.09%6K
---41K
---1K
---9K
---9K
---23K
----
----
Income before tax
20.62%-3.83M
-8.66%-5.44M
-12.52%-4.81M
-47.95%-21.11M
-33.06%-7M
-47.42%-4.83M
-56.78%-5.01M
-68.43%-4.27M
-41.04%-14.27M
-146.86%-5.26M
Income tax
-57.31%-527K
32.52%-359K
-330K
-1.43M
-558K
-335K
-532K
0
0
Net income
26.44%-3.3M
-13.56%-5.08M
-4.80%-4.48M
-37.97%-19.69M
-22.46%-6.45M
-37.18%-4.49M
-40.13%-4.48M
-68.43%-4.27M
-41.04%-14.27M
-146.86%-5.26M
Net income continuous Operations
26.44%-3.3M
-13.56%-5.08M
-4.80%-4.48M
-37.97%-19.69M
-22.46%-6.45M
-37.18%-4.49M
-40.13%-4.48M
-68.43%-4.27M
-41.04%-14.27M
-146.86%-5.26M
Minority interest income
0
98.63%-1K
0
Net income attributable to the parent company
26.44%-3.3M
-13.56%-5.08M
-4.80%-4.48M
-37.98%-19.69M
-22.46%-6.45M
-37.18%-4.49M
-40.13%-4.48M
-68.49%-4.27M
-42.06%-14.27M
-149.55%-5.26M
Preferred stock dividends
-6.98%1.52M
-100.77%-1K
Other preferred stock dividends
0
-95.41%340K
0
340K
741.14%7.4M
0
Net income attributable to common stockholders
31.61%-3.3M
-13.56%-5.08M
-4.80%-4.48M
13.64%-20.03M
-22.46%-6.45M
-47.57%-4.83M
-40.13%-4.48M
62.71%-4.27M
-84.67%-23.19M
-68.74%-5.26M
Basic earnings per share
36.67%-0.19
-21.43%-0.34
3.23%-0.3
31.05%-1.31
-12.82%-0.44
-20.00%-0.3
-16.67%-0.28
76.15%-0.31
71.21%-1.9
72.14%-0.39
Diluted earnings per share
36.67%-0.19
-21.43%-0.34
3.23%-0.3
31.05%-1.31
-12.82%-0.44
-20.00%-0.3
-16.67%-0.28
76.15%-0.31
71.21%-1.9
72.14%-0.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -15.40%4.22M15.80%5.82M21.78%5.18M51.19%21.58M38.97%7.32M52.24%4.99M57.21%5.03M67.60%4.25M40.49%14.27M146.95%5.27M
Selling and administrative expenses -91.23%212K74.37%2.69M32.99%2.2M52.27%9.86M70.80%4.25M85.42%2.42M21.82%1.54M16.63%1.66M28.73%6.47M115.61%2.49M
-General and administrative expense -91.23%212K74.37%2.69M32.99%2.2M52.27%9.86M70.80%4.25M85.42%2.42M21.82%1.54M16.63%1.66M28.73%6.47M115.61%2.49M
Research and development costs 55.88%4.01M-10.10%3.13M14.63%2.98M50.29%11.72M10.51%3.07M30.32%2.57M80.38%3.49M132.29%2.6M52.02%7.8M183.86%2.78M
Operating profit 15.40%-4.22M-15.80%-5.82M-21.78%-5.18M-51.19%-21.58M-38.97%-7.32M-52.24%-4.99M-57.21%-5.03M-67.60%-4.25M-40.49%-14.27M-146.95%-5.27M
Net non-operating interest income expense 124.71%382K1,365.38%381K18,100.00%364K8,433.33%512K15,650.00%315K8,400.00%170K1,200.00%26K2K-86.36%6K2K
Non-operating interest income 124.71%382K1,365.38%381K18,100.00%364K8,433.33%512K15,650.00%315K8,400.00%170K1,200.00%26K--2K-86.36%6K--2K
Other net income (expense) 166.67%6K55.56%-4K126.09%6K-41K-1K-9K-9K-23K
Gain on sale of security 166.67%6K55.56%-4K126.09%6K---41K---1K---9K---9K---23K--------
Income before tax 20.62%-3.83M-8.66%-5.44M-12.52%-4.81M-47.95%-21.11M-33.06%-7M-47.42%-4.83M-56.78%-5.01M-68.43%-4.27M-41.04%-14.27M-146.86%-5.26M
Income tax -57.31%-527K32.52%-359K-330K-1.43M-558K-335K-532K00
Net income 26.44%-3.3M-13.56%-5.08M-4.80%-4.48M-37.97%-19.69M-22.46%-6.45M-37.18%-4.49M-40.13%-4.48M-68.43%-4.27M-41.04%-14.27M-146.86%-5.26M
Net income continuous Operations 26.44%-3.3M-13.56%-5.08M-4.80%-4.48M-37.97%-19.69M-22.46%-6.45M-37.18%-4.49M-40.13%-4.48M-68.43%-4.27M-41.04%-14.27M-146.86%-5.26M
Minority interest income 098.63%-1K0
Net income attributable to the parent company 26.44%-3.3M-13.56%-5.08M-4.80%-4.48M-37.98%-19.69M-22.46%-6.45M-37.18%-4.49M-40.13%-4.48M-68.49%-4.27M-42.06%-14.27M-149.55%-5.26M
Preferred stock dividends -6.98%1.52M-100.77%-1K
Other preferred stock dividends 0-95.41%340K0340K741.14%7.4M0
Net income attributable to common stockholders 31.61%-3.3M-13.56%-5.08M-4.80%-4.48M13.64%-20.03M-22.46%-6.45M-47.57%-4.83M-40.13%-4.48M62.71%-4.27M-84.67%-23.19M-68.74%-5.26M
Basic earnings per share 36.67%-0.19-21.43%-0.343.23%-0.331.05%-1.31-12.82%-0.44-20.00%-0.3-16.67%-0.2876.15%-0.3171.21%-1.972.14%-0.39
Diluted earnings per share 36.67%-0.19-21.43%-0.343.23%-0.331.05%-1.31-12.82%-0.44-20.00%-0.3-16.67%-0.2876.15%-0.3171.21%-1.972.14%-0.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg